Charles McNerney
Direktor/Vorstandsmitglied bei HAPBEE TECHNOLOGIES, INC.
Vermögen: - $ am 30.04.2024
Profil
Charles E.
McNerney is an Independent Director at EMulate Therapeutics, Inc. and Hapbee Technologies, Inc. He was the Chief Information Security Officer at Microsoft Corp.
from 1993 to 2019 and the Chief Information Security Officer & VP at Expedia Group, Inc. from 2019 to 2022.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.10.2022 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Charles McNerney
| Unternehmen | Position | Beginn |
|---|---|---|
| HAPBEE TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 22.05.2019 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Direktor/Vorstandsmitglied | 01.01.2016 |
Ehemalige bekannte Positionen von Charles McNerney
| Unternehmen | Position | Ende |
|---|---|---|
| EXPEDIA GROUP, INC. | Corporate Officer/Principal | 01.03.2022 |
| MICROSOFT CORPORATION | Corporate Officer/Principal | 01.11.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
| EXPEDIA GROUP, INC. | Consumer Services |
| MICROSOFT CORPORATION | Technology Services |
| Private Unternehmen | 1 |
|---|---|
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
